Antisense Therapeutics Limited (ANP.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.20000.0000 (0.00%)
At close: 4:10PM AEST
| Previous close | 0.2000 |
| Open | 0.2050 |
| Bid | 0.2000 x 50000000 |
| Ask | 0.2100 x 34112000 |
| Day's range | 0.2000 - 0.2050 |
| 52-week range | 0.0430 - 0.2700 |
| Volume | 372,373 |
| Avg. volume | 2,422,354 |
| Market cap | 114.811M |
| Beta (5Y monthly) | 0.87 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0070 |
| Earnings date | 01 Mar 2016 - 05 Mar 2016 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is Antisense Therapeutics (ASX:ANP) In A Good Position To Deliver On Growth Plans?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
- Business Wire
Antisense Therapeutics Announces a Poster Presentation on the Muscular Dystrophy Association Virtual Conference 2020 website
Antisense Therapeutics (ASX:ANP | US OTC:ATHJY), an Australian biopharmaceutical company developing and commercializing antisense pharmaceuticals for unmet need in rare diseases announces a virtual poster presentation on the Muscular Dystrophy Association (MDA) Virtual 2020 Conference website.
- Simply Wall St.
Antisense Therapeutics (ASX:ANP) Is In A Good Position To Deliver On Growth Plans
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
© 2021 Verizon Media. All rights reserved.
